Research progress of coronary artery occlusion associated with transcatheter aortic valve implantation_Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Authors：

DU Zhaona ¹ , LU Xiuyan ² , SHAO Yibing ² ,  XIA Wei ²

1. School of Clinical Medicine, Weifang Medical University, Weifang, 261000, Shandong, P. R. China;
2. First Department of Cardiology, Qingdao Municipal Hospital East Hospital, Qingdao Hospital, University of Health and Rehabilitation Sciences, Qingdao, 266000, Shandong, P. R. China;

Corresponding author：

XIA Wei, Email: summer0419163@163.com

Keywords：

Transcatheter aortic valve implantation; coronary artery occlusion; prevention; treatment; review

DOI：

10.7507/1007-4848.202210042

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Transcatheter aortic valve implantation (TAVI) has become the main treatment for elderly patients with middle and high risk aortic stenosis. However, coronary artery occlusion (CAO) related to TAVI is a very serious complication, which often leads to poor prognosis. Therefore, active preoperative prevention is particularly important. Preoperative computed tomography evaluation, bioprosthetic or native aortic scallop intentional laceration and chimney stent implantation technology can prevent TAVI-related coronary orifice obstruction. Ensuring commissural alignment during operation can reduce the occurrence of coronary occlusion, but its long-term prognosis needs further study. In addition, percutaneous coronary intervention is the main treatment, but there are problems such as difficult coronary access after TAVI. This article summarized the research progress in the mechanism, prevention and treatment of CAO related to TAVI.

Citation： DU Zhaona, LU Xiuyan, SHAO Yibing, XIA Wei. Research progress of coronary artery occlusion associated with transcatheter aortic valve implantation. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2023, 30(8): 1188-1192. doi: 10.7507/1007-4848.202210042 Copy

1.	Kaul S. Raising the evidentiary bar for guideline recommendations for TAVR: JACC review topic of the week. J Am Coll Cardiol, 2020, 76(8): 985-991.
2.	Ullah W, Zahid S, Hamzeh I, et al. Trends and predictors of transcatheter aortic valve implantation related in-hospital mortality (from the National Inpatient Sample Database). Am J Cardiol, 2021, 143: 97-103.
3.	Guedeney P, Collet JP. Aortic stenosis: An update. Rev Med Interne, 2022, 43(3): 145-151.
4.	Khan JM, Babaliaros VC, Greenbaum AB, et al. Preventing coronary obstruction during transcatheter aortic valve replacement: Results from the multicenter international BASILICA registry. JACC Cardiovasc Interv, 2021, 14(9): 941-948.
5.	Ribeiro HB, Webb JG, Makkar RR, et al. Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: Insights from a large multicenter registry. J Am Coll Cardiol, 2013, 62(17): 1552-1562.
6.	Akinseye OA, Jha SK, Ibebuogu UN. Clinical outcomes of coronary occlusion following transcatheter aortic valve replacement: A systematic review. Cardiovasc Revasc Med, 2018, 19(2): 229-236.
7.	Tada H. Catheter ablation of tachyarrhythmias from the aortic sinuses of valsalva—When and how? Circ J, 2012, 76(4): 791-800.
8.	Westermann D, Ludwig S, Kalbacher D, et al. Prevention of coronary obstruction in patients at risk undergoing transcatheter aortic valve implantation: The Hamburg BASILICA experience. Clin Res Cardiol, 2021, 110(12): 1900-1911.
9.	Oh JH, Kobayashi Y, Kang G, et al. Distance between valvular leaflet and coronary ostium predicting risk of coronary obstruction during TAVR. Int J Cardiol Heart Vasc, 2021, 37: 100917.
10.	Khan JM, Greenbaum AB, Babaliaros VC, et al. The BASILICA trial: Prospective multicenter investigation of intentional leaflet laceration to prevent TAVR coronary obstruction. JACC Cardiovasc Interv, 2019, 12(13): 1240-1252.
11.	De Backer O, Søndergaard L. Redo-TAVR: What about the coronary arteries? JACC Cardiovasc Interv, 2020, 13(22): 2628-2630.
12.	Garot P. TAVR-related coronary obstruction: Preventive wires or stenting? JACC Cardiovasc Interv, 2020, 13(6): 748-750.
13.	Carroll JD. The splitting of leaflets to prevent coronary occlusion during TAVR. JACC Cardiovasc Interv, 2019, 12(13): 1253-1255.
14.	Redondo A, Baladrón Zorita C, Tchétché D, et al. Commissural versus coronary optimized alignment during transcatheter aortic valve replacement. JACC Cardiovasc Interv, 2022, 15(2): 135-146.
15.	Wang X, De Backer O, Bieliauskas G, et al. Cusp symmetry and coronary ostial eccentricity and its impact on coronary access following TAVR. JACC Cardiovasc Interv, 2022, 15(2): 123-134.
16.	Tagliari AP, Petersen Saadi R, Medronha EF, et al. The use of BASILICA technique to prevent coronary obstruction in a TAVI-TAVI procedure. J Clin Med, 2021, 10(23): 5534.
17.	Ribeiro HB, Rodés-Cabau J, Blanke P, et al. Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: Insights from the VIVID registry. Eur Heart J, 2018, 39(8): 687-695.
18.	Du Y, Wang Z, Liu W, et al. Transcatheter aortic valve implantation in Sievers Type 0 vs. Type 1 bicuspid aortic valve morphology: Systematic review and meta-analysis. Front Cardiovasc Med, 2021, 8: 771789.
19.	王墨扬, 许亮, 裴汉军, 等. 15例拟行经导管主动脉瓣置换术患者主动脉根部影像学与临床应用—单中心早期经验. 中国循环杂志, 2014, 29(9): 714-717.
20.	Kitamura M, Wilde J, Dumpies O, et al. Risk assessment of coronary obstruction during transcatheter aortic valve replacement: Insights from post-BASILICA computed tomography. JACC Cardiovasc Interv, 2022, 15(5): 496-507.
21.	Gatti M, Gallone G, Poggi V, et al. Diagnostic accuracy of coronary computed tomography angiography for the evaluation of obstructive coronary artery disease in patients referred for transcatheter aortic valve implantation: A systematic review and meta-analysis. Eur Radiol, 2022, 32(8): 5189-5200.
22.	Komatsu I, Leipsic J, Webb JG, et al. Coronary ostial eccentricity in severe aortic stenosis: Guidance for BASILICA transcatheter leaflet laceration. J Cardiovasc Comput Tomogr, 2020, 14(6): 516-519.
23.	Kitamura M, Majunke N, Holzhey D, et al. Systematic use of intentional leaflet laceration to prevent TAVI-induced coronary obstruction: Feasibility and early clinical outcomes of the BASILICA technique. EuroIntervention, 2020, 16(8): 682-690.
24.	Khan JM, Greenbaum AB, Babaliaros VC, et al. BASILICA trial: One-year outcomes of transcatheter electrosurgical leaflet laceration to prevent TAVR coronary obstruction. Circ Cardiovasc Interv, 2021, 14(5): e010238.
25.	Sharma RK, Tuttle MK, Poulin MF, et al. CoreValve bioprosthesis dysfunction treated with a Sapien 3 valve-in-valve transcatheter aortic valve replacement and BASILICA technique. Catheter Cardiovasc Interv, 2021, 98(2): 403-406.
26.	Tang GHL, Zaid S, Fuchs A, et al. Alignment of transcatheter aortic-valve neo-commissures (ALIGN TAVR): Impact on final valve orientation and coronary artery overlap. JACC Cardiovasc Interv, 2020, 13(9): 1030-1042.
27.	Tarantini G, Nai Fovino L, Scotti A, et al. Coronary access after transcatheter aortic valve replacement with commissural alignment: The ALIGN-ACCESS study. Circ Cardiovasc Interv, 2022, 15(2): e011045.
28.	Kandzari DE, Yadav PK. Coronary occlusion during TAVR: If you think about it, protect it. JACC Cardiovasc Interv, 2020, 13(6): 762-764.
29.	Mercanti F, Rosseel L, Neylon A, et al. Chimney stenting for coronary occlusion during TAVR: Insights from the Chimney registry. JACC Cardiovasc Interv, 2020, 13(6): 751-761.
30.	Palmerini T, Chakravarty T, Saia F, et al. Coronary protection to prevent coronary obstruction during TAVR: A multicenter international registry. JACC Cardiovasc Interv, 2020, 13(6): 739-747.
31.	Ruggiero R, Khokhar A, Zlahoda-Huzior A, et al. Coronary access after Chimney stenting during valve-in-valve TAVI for failed surgical bioprosthetic valves: Impact of valve design. Can J Cardiol, 2022, 38(8): 1320-1322.
32.	Vincent F, Ternacle J, Denimal T, et al. Transcatheter aortic valve replacement in bicuspid aortic valve stenosis. Circulation, 2021, 143(10): 1043-1061.
33.	Elkoumy A, Jose J, Terkelsen CJ, et al. Safety and efficacy of Myval implantation in patients with severe bicuspid aortic valve stenosis—A multicenter real-world experience. J Clin Med, 2022, 11(2): 443.
34.	Majmundar M, Kumar A, Doshi R, et al. Meta-analysis of transcatheter aortic valve implantation in patients with stenotic bicuspid versus tricuspid aortic valve. Am J Cardiol, 2021, 145: 102-110.
35.	Kawashima H, Serruys PW, Mylotte D, et al. Operator preference and determinants of size selection when additional intermediate-size aortic transcatheter heart valves are made available. Int J Cardiol, 2021, 338: 168-173.
36.	Liang Y, Dhoble A, Pakanati A, et al. Catastrophic cardiac events during transcatheter aortic valve replacement. Can J Cardiol, 2021, 37(10): 1522-1529.
37.	Spina R, Khalique O, George I, et al. Acute left main stem coronary occlusion following transcatheter aortic valve replacement in a patient without recognized coronary obstruction risk factors: A case report. Eur Heart J Case Rep, 2018, 2(4): yty112.
38.	Jabbour RJ, Tanaka A, Finkelstein A, et al. Delayed coronary obstruction after transcatheter aortic valve replacement. J Am Coll Cardiol, 2018, 71(14): 1513-1524.
39.	Barbanti M, Costa G, Picci A, et al. Coronary cannulation after transcatheter aortic valve replacement: The RE-ACCESS study. JACC Cardiovasc Interv, 2020, 13(21): 2542-2555.
40.	Weferling M, Hamm CW, Kim WK. Percutaneous coronary intervention in transcatheter aortic valve implantation patients: Overview and practical management. Front Cardiovasc Med, 2021, 8: 653768.
41.	Ochiai T, Chakravarty T, Yoon SH, et al. Coronary access after TAVR. JACC Cardiovasc Interv, 2020, 13(6): 693-705.

1. Kaul S. Raising the evidentiary bar for guideline recommendations for TAVR: JACC review topic of the week. J Am Coll Cardiol, 2020, 76(8): 985-991.
2. Ullah W, Zahid S, Hamzeh I, et al. Trends and predictors of transcatheter aortic valve implantation related in-hospital mortality (from the National Inpatient Sample Database). Am J Cardiol, 2021, 143: 97-103.
3. Guedeney P, Collet JP. Aortic stenosis: An update. Rev Med Interne, 2022, 43(3): 145-151.
4. Khan JM, Babaliaros VC, Greenbaum AB, et al. Preventing coronary obstruction during transcatheter aortic valve replacement: Results from the multicenter international BASILICA registry. JACC Cardiovasc Interv, 2021, 14(9): 941-948.
5. Ribeiro HB, Webb JG, Makkar RR, et al. Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: Insights from a large multicenter registry. J Am Coll Cardiol, 2013, 62(17): 1552-1562.
6. Akinseye OA, Jha SK, Ibebuogu UN. Clinical outcomes of coronary occlusion following transcatheter aortic valve replacement: A systematic review. Cardiovasc Revasc Med, 2018, 19(2): 229-236.
7. Tada H. Catheter ablation of tachyarrhythmias from the aortic sinuses of valsalva—When and how? Circ J, 2012, 76(4): 791-800.
8. Westermann D, Ludwig S, Kalbacher D, et al. Prevention of coronary obstruction in patients at risk undergoing transcatheter aortic valve implantation: The Hamburg BASILICA experience. Clin Res Cardiol, 2021, 110(12): 1900-1911.
9. Oh JH, Kobayashi Y, Kang G, et al. Distance between valvular leaflet and coronary ostium predicting risk of coronary obstruction during TAVR. Int J Cardiol Heart Vasc, 2021, 37: 100917.
10. Khan JM, Greenbaum AB, Babaliaros VC, et al. The BASILICA trial: Prospective multicenter investigation of intentional leaflet laceration to prevent TAVR coronary obstruction. JACC Cardiovasc Interv, 2019, 12(13): 1240-1252.
11. De Backer O, Søndergaard L. Redo-TAVR: What about the coronary arteries? JACC Cardiovasc Interv, 2020, 13(22): 2628-2630.
12. Garot P. TAVR-related coronary obstruction: Preventive wires or stenting? JACC Cardiovasc Interv, 2020, 13(6): 748-750.
13. Carroll JD. The splitting of leaflets to prevent coronary occlusion during TAVR. JACC Cardiovasc Interv, 2019, 12(13): 1253-1255.
14. Redondo A, Baladrón Zorita C, Tchétché D, et al. Commissural versus coronary optimized alignment during transcatheter aortic valve replacement. JACC Cardiovasc Interv, 2022, 15(2): 135-146.
15. Wang X, De Backer O, Bieliauskas G, et al. Cusp symmetry and coronary ostial eccentricity and its impact on coronary access following TAVR. JACC Cardiovasc Interv, 2022, 15(2): 123-134.
16. Tagliari AP, Petersen Saadi R, Medronha EF, et al. The use of BASILICA technique to prevent coronary obstruction in a TAVI-TAVI procedure. J Clin Med, 2021, 10(23): 5534.
17. Ribeiro HB, Rodés-Cabau J, Blanke P, et al. Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: Insights from the VIVID registry. Eur Heart J, 2018, 39(8): 687-695.
18. Du Y, Wang Z, Liu W, et al. Transcatheter aortic valve implantation in Sievers Type 0 vs. Type 1 bicuspid aortic valve morphology: Systematic review and meta-analysis. Front Cardiovasc Med, 2021, 8: 771789.
19. 王墨扬, 许亮, 裴汉军, 等. 15例拟行经导管主动脉瓣置换术患者主动脉根部影像学与临床应用—单中心早期经验. 中国循环杂志, 2014, 29(9): 714-717.
20. Kitamura M, Wilde J, Dumpies O, et al. Risk assessment of coronary obstruction during transcatheter aortic valve replacement: Insights from post-BASILICA computed tomography. JACC Cardiovasc Interv, 2022, 15(5): 496-507.
21. Gatti M, Gallone G, Poggi V, et al. Diagnostic accuracy of coronary computed tomography angiography for the evaluation of obstructive coronary artery disease in patients referred for transcatheter aortic valve implantation: A systematic review and meta-analysis. Eur Radiol, 2022, 32(8): 5189-5200.
22. Komatsu I, Leipsic J, Webb JG, et al. Coronary ostial eccentricity in severe aortic stenosis: Guidance for BASILICA transcatheter leaflet laceration. J Cardiovasc Comput Tomogr, 2020, 14(6): 516-519.
23. Kitamura M, Majunke N, Holzhey D, et al. Systematic use of intentional leaflet laceration to prevent TAVI-induced coronary obstruction: Feasibility and early clinical outcomes of the BASILICA technique. EuroIntervention, 2020, 16(8): 682-690.
24. Khan JM, Greenbaum AB, Babaliaros VC, et al. BASILICA trial: One-year outcomes of transcatheter electrosurgical leaflet laceration to prevent TAVR coronary obstruction. Circ Cardiovasc Interv, 2021, 14(5): e010238.
25. Sharma RK, Tuttle MK, Poulin MF, et al. CoreValve bioprosthesis dysfunction treated with a Sapien 3 valve-in-valve transcatheter aortic valve replacement and BASILICA technique. Catheter Cardiovasc Interv, 2021, 98(2): 403-406.
26. Tang GHL, Zaid S, Fuchs A, et al. Alignment of transcatheter aortic-valve neo-commissures (ALIGN TAVR): Impact on final valve orientation and coronary artery overlap. JACC Cardiovasc Interv, 2020, 13(9): 1030-1042.
27. Tarantini G, Nai Fovino L, Scotti A, et al. Coronary access after transcatheter aortic valve replacement with commissural alignment: The ALIGN-ACCESS study. Circ Cardiovasc Interv, 2022, 15(2): e011045.
28. Kandzari DE, Yadav PK. Coronary occlusion during TAVR: If you think about it, protect it. JACC Cardiovasc Interv, 2020, 13(6): 762-764.
29. Mercanti F, Rosseel L, Neylon A, et al. Chimney stenting for coronary occlusion during TAVR: Insights from the Chimney registry. JACC Cardiovasc Interv, 2020, 13(6): 751-761.
30. Palmerini T, Chakravarty T, Saia F, et al. Coronary protection to prevent coronary obstruction during TAVR: A multicenter international registry. JACC Cardiovasc Interv, 2020, 13(6): 739-747.
31. Ruggiero R, Khokhar A, Zlahoda-Huzior A, et al. Coronary access after Chimney stenting during valve-in-valve TAVI for failed surgical bioprosthetic valves: Impact of valve design. Can J Cardiol, 2022, 38(8): 1320-1322.
32. Vincent F, Ternacle J, Denimal T, et al. Transcatheter aortic valve replacement in bicuspid aortic valve stenosis. Circulation, 2021, 143(10): 1043-1061.
33. Elkoumy A, Jose J, Terkelsen CJ, et al. Safety and efficacy of Myval implantation in patients with severe bicuspid aortic valve stenosis—A multicenter real-world experience. J Clin Med, 2022, 11(2): 443.
34. Majmundar M, Kumar A, Doshi R, et al. Meta-analysis of transcatheter aortic valve implantation in patients with stenotic bicuspid versus tricuspid aortic valve. Am J Cardiol, 2021, 145: 102-110.
35. Kawashima H, Serruys PW, Mylotte D, et al. Operator preference and determinants of size selection when additional intermediate-size aortic transcatheter heart valves are made available. Int J Cardiol, 2021, 338: 168-173.
36. Liang Y, Dhoble A, Pakanati A, et al. Catastrophic cardiac events during transcatheter aortic valve replacement. Can J Cardiol, 2021, 37(10): 1522-1529.
37. Spina R, Khalique O, George I, et al. Acute left main stem coronary occlusion following transcatheter aortic valve replacement in a patient without recognized coronary obstruction risk factors: A case report. Eur Heart J Case Rep, 2018, 2(4): yty112.
38. Jabbour RJ, Tanaka A, Finkelstein A, et al. Delayed coronary obstruction after transcatheter aortic valve replacement. J Am Coll Cardiol, 2018, 71(14): 1513-1524.
39. Barbanti M, Costa G, Picci A, et al. Coronary cannulation after transcatheter aortic valve replacement: The RE-ACCESS study. JACC Cardiovasc Interv, 2020, 13(21): 2542-2555.
40. Weferling M, Hamm CW, Kim WK. Percutaneous coronary intervention in transcatheter aortic valve implantation patients: Overview and practical management. Front Cardiovasc Med, 2021, 8: 653768.
41. Ochiai T, Chakravarty T, Yoon SH, et al. Coronary access after TAVR. JACC Cardiovasc Interv, 2020, 13(6): 693-705.

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Research progress of coronary artery occlusion associated with transcatheter aortic valve implantation

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content